ANTHROCELL

[ Pharmaceutical preparations produced using biomaterials via biotechnological processes for the treatment of cancer, autoimmune diseases, cardiovascular disease, inflammatory diseases, macular degeneration, transplant rejection, multiple sclerosis, and viral infections; biotechnological preparations for medical use, namely, monoclonal antibodies for the treatment of cancer, autoimmune diseases, cardiovascular disease, inflammatory diseases, macular degeneration, transplant rejection, multiple sclerosis, and viral infections; biological and chemical products for medical use, namely, fully human monoclonal antibodies ]

Manufacture for others of pharmaceuticals produced using biomaterials via biotechnological processes; manufacture for others of biotechnological preparations for medical use; manufacture for others of proteins, including biopharmaceutical proteins, for medical use

Pharmaceutical and biotechnology research and testing in the field of human cell-based genetic expression of proteins